Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

MicroRNA-212 inhibits proliferation of gastric cancer by directly repressing retinoblastoma binding protein 2.

Authors: Jiping, Z  Ming, F  Lixiang, W  Xiuming, L  Yuqun, S  Han, Y  Zhifang, L  Yundong, S  Shili, L  Chunyan, C  Jihui, J 
Citation: Jiping Z, etal., J Cell Biochem. 2013 Dec;114(12):2666-72. doi: 10.1002/jcb.24613.
Pubmed: (View Article at PubMed) PMID:23794145
DOI: Full-text: DOI:10.1002/jcb.24613

Retinoblastoma binding protein 2 (RBP2), a newly found histone demethylase, is overexpressed in gastric cancer. We examined the upstream regulatory mechanism of RBP2 at the microRNA (miRNA) level and the role in gastric carcinogenesis. We used bioinformatics to predict that microRNA-212 (miR-212) might be a direct upstream regulator of RBP2 and verified the regulation in gastric epithelial-derived cell lines. Overexpression of miR-212 significantly inhibited the expression levels of RBP2, whereas knockdown of miR-212 promoted RBP2 expression. Furthermore, we identified the putative miR-212 targeting sequence in the RBP2 3' UTR by luciferase assay. MiR-212 inhibited the colony formation ability of cells by repressing RBP2 expression and increasing that of P21(CIP1) and P27(kip1), both critical in cell cycle arrest. In addition, the expression of RBP2 and miR-212 in tumor tissue and matched normal tissue from 18 patients further supported the results in vivo. MiR-212 directly regulates the expression of RBP2 and inhibits cell growth in gastric cancer, which may provide new clues to treatment.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 9588529
Created: 2014-10-30
Species: All species
Last Modified: 2014-10-30
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.